A Phase III Randomized Trial of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to find out whether it is better to receive the drug Metformin, with the usual treatment for breast cancer, or not.
Description
The purpose of this study is to find out whether it is better to receive the drug Metformin, with the usual treatment for breast cancer, or not.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast Cancer
-
Age: - 100 Years
-
Gender: Female
Updated on
20 Apr 2024.
Study ID: 1106005988
